Russell Investments Group’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-382
Closed -$3.84K 3769
2024
Q3
$3.84K Buy
382
+37
+11% +$540 ﹤0.01% 3270
2024
Q2
$5.38K Buy
345
+13
+4% +$218 ﹤0.01% 3196
2024
Q1
$7.27K Buy
332
+319
+2,454% +$7.08K ﹤0.01% 2891
2023
Q4
$255 Sell
13
-39
-75% -$712 ﹤0.01% 3168
2023
Q3
$963 Buy
+52
New +$936 ﹤0.01% 3341
2021
Q4
Sell
-1,774
Closed -$79K 3078
2021
Q3
$79K Sell
1,774
-31
-2% -$1.3K ﹤0.01% 2910
2021
Q2
$83K Sell
1,805
-160
-8% -$8.17K ﹤0.01% 3082
2021
Q1
$108K Buy
+1,965
New +$120K ﹤0.01% 2969
2020
Q3
Sell
-443
Closed -$49K 3231
2020
Q2
$49K Buy
+443
New +$31.5K ﹤0.01% 2987
2020
Q1
Sell
-2,002
Closed -$277K 3107
2019
Q4
$277K Buy
+2,002
New +$260K ﹤0.01% 2606

Other funds holding OPTN

Russell Investments Group's OPTN Position: Q4 2024 in Review

Russell Investments Group sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 382 shares — an estimated $3.84K sold.

Russell Investments Group first reported a position in OPTN in Q4 2019 and held it in 10 quarters. The position peaked at $277K in Q4 2019. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Russell Investments Group reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 382 OptiNose shares in Q4 2024, an estimated $3.84K.
  • Russell Investments Group first reported a position in OptiNose in Q4 2019 and held it in 10 quarters.
  • Russell Investments Group's OptiNose position peaked at $277K in Q4 2019.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.